Business This Week
Moneylife Digital Team
28 August 2026
India is drafting official quality benchmarks for semaglutide, the active ingredient in weight-loss drugs like Ozempic and Wegovy, ahead of a looming generics boom as patents expire. The Indian Pharmacopoeia Commission (IPC) is…
